ORIONHEALT FPO NZ (ASX: OHE) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


ORIONHEALT FPO NZ Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Latest News

OHE ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size


Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr George Roger Wayne France Non-Executive Deputy ChairmanNon-Executive Director Feb 2013
Mr France was the Chief Financial Officer of two listed companies for 10 years followed by 15 years as a corporate advisory partner at PwC and one of its predecessor firms, Coopers & Lybrand. Roger is Chairman of Tappenden Holdings, Director of Southern Cross Medical Care Society, Chairman of the Deep South National Science Challenge, Trustee of the University of Auckland Foundation, an advisory panel member of NEXT Foundation and a member of the Treasury Commercial Operations Advisory Board. Roger's past Board appointments include Fonterra, Air New Zealand, Fisher and Paykel Healthcare, Blue Star Group and Team New Zealand. He was Chancellor of The University of Auckland between 2009 and 2012.
Mr Paul N Shearer Non-Executive Director Feb 2013
Mr Shearer is the Senior Vice President of Sales & Marketing for Fisher & Paykel Healthcare. Paul has over 25 years international experience working within the healthcare industry gained while managing and establishing FPH sales offices in North America, Europe and Asia. He is responsible for sales offices and employees in 35 countries. Paul is a Director of a number of Fisher & Paykel Healthcare subsidiaries and his prior experience includes positions held at ICL and Computercorp.
Mr Michael Falconer Non-Executive Director Oct 2018
Mr Falconer is a seasoned global business advisor, executive and investor with a background in investment banking, senior management roles in companies and technology start-up investing and management. He is currently a Partner at High St Capital Partners. Over the last five years, Michael has provided advice to business owners and is a founding investor in technology start-ups NextMinute and OnSide. Prior to this, Michael spent more than 6 years in CFO and CEO roles at Carter Holt Harvey. Michael has worked with a range of businesses across different sectors and levels of maturity, assisting owners to drive value. Michael was acknowledged for his work with Synlait with the INFINZ 2015 Mergers & Acquisitions Transaction of the Year as Commercial Advisor to Synlait Farms.
Mr Andrew Alan Ferrier Non-Executive ChairmanNon-Executive Director Dec 2014
Mr Ferrier has held a number of director and executive positions for multinationals and has 30 years of experience in international business. From 2003 to 2011, Andrew was Chief Executive Officer of Fonterra Co-Operative Group. Andrew currently runs his own investment company, Canz Capital, is Chairman of the New Zealand Government's economic development agency New Zealand Trade and Enterprise, sits on the Council of the University of Auckland and, in addition to Orion Health, sits on the boards of Bunge Ltd. in New York and George Weston Ltd. in Toronto, as well as other private and charitable boards.
Mr Ian McCrae Chief Executive OfficerExecutive Director Mar 2001
Mr McCrae before founding Orion Health, Ian was a senior telecommunications consultant for Clearfield Consulting, a network designer at Ernst & Young and a senior business analyst for the London Stock Exchange.
Mr Ronald Andrews Non-Executive Director Sep 2016
Mr Andrews has close to 30 years in governance and executive roles in the US Clinical and Molecular Diagnostics industry. He sits on the Board of Directors for several companies, both public and private, and is active on a number of charitable boards. He has experience working with the US government in Washington and speaks regularly to industry groups. He served as the President of the Genetic Science Division for Thermo Fisher Scientific until December 2014. Prior to this he held a number of high profile executive roles including President of the Medical Sciences Venture within the Life Technologies Corporation, and he served as CEO of Clarient, a public company on the NASDAQ, which was sold to General Electric Healthcare in December 2010.
Ms Maureen Shaddick Acting Company Secretary Oct 2018
Enjel Phoon Company Secretary
Maureen Shaddick Acting Company Secretary
Enjel Phoon Company Secretary

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
McCrae Limited 97,526,723 49.75%
Geoffrey Alexander Cumming 15,817,777 8.07%
Pioneer Capital I Nominees Limited 12,316,447 6.28%
New Zealand Central Securities Depository Limited 5,709,051 2.91%
Hamish Alexander Kennedy 4,837,643 2.47%
Telstra Holdings Pty Ltd 3,508,772 1.79%
HSBC Custody Nominees (Australia) Limited 3,039,155 1.55%
Emerald Capital Limited 2,980,000 1.52%
Deborah Mary Thomson & Mark James Thomson 2,173,174 1.11%
CANZ Capital Limited 1,466,666 0.75%
ASB Nominees Limited 1,253,317 0.64%
Mark Stewart Capill & Bronwyn Jane Capill & Integrity Trustees Limited 1,222,508 0.62%
Jacon Investments Limited 1,222,222 0.62%
Paul Nigel Shearer & Sonya Maree Shearer & Mark Edgar Wilson 1,222,222 0.62%
Michael Brian Clegg & Kylie Anne Clegg 1,212,500 0.62%
J P Morgan Nominees Australia Limited 1,194,377 0.61%
Edwin Weng Kit Ng 1,170,942 0.60%
Orion Health Corporate Trustee Limited 1,164,730 0.59%
Gordon Stanley McCrae 1,090,598 0.56%
FNZ Custodians Limited 888,303 0.45%